CYClOTHIALIDINE-E
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 6jAv78l7Mqa |
|---|---|
| InChI | InChI=1S/C25H33N5O11S/c1-10-16(32)6-17(33)11-8-42-9-14(21(27)36)29-22(37)13(7-41-25(40)19(10)11)28-23(38)20-15(31)4-5-30(20)24(39)12(26)2-3-18(34)35/h6,12-15,20,31-33H,2-5,7-9,26H2,1H3,(H2,27,36)(H,28,38)(H,29,37)(H,34,35)/t12-,13-,14-,15+,20-/m0/s1 |
| InChIKey | PVRMXRCYXJPYJV-MOMPZSSISA-N |
| Mol Weight | 611.6 g/mol |
| Molecular Formula | C25H33N5O11S |
| Exact Mass | 611.189728 g/mol |
| Enantiomer InChIKey | PVRMXRCYXJPYJV-BATKGTNTSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
Propanamide, 2-(dimethylamino)-N-[2-methyl-1-[[3,3a,12,13,14,15,16,16a-octahydro-8-methoxy-13,16-dioxo-14-(phenylmethyl)-5,9-metheno-9H-pyrrolo[3,2-b][1,5,8]oxadiazacyclopentadecin-1(2H)-yl]carbonyl]propyl]-
VERRUCAMIDE_A
PALIURINE-E
Benzenepropanamide, .alpha.-(dimethylamino)-N-[2-methyl-1-[[3,3a,11,12,13,14,15,15a-octahydro-12,15-dioxo-13-(phenylmethyl)-5,8-ethenopyrrolo[3,2-b][1,5,8]oxadiazacyclotetradecin-1(2H)-yl]carbonyl]butyl]-
SATIVNINE-G
#21B;N-(9-FLUORENYLMETHYLOXYCARBONYL)-L-METHIONYLGLYCYL-L-LEUCYL-L-PROLYL-S-[(E,E)-8-O-(2-N-METHYL-AMINOBENZOYL)-3,7,11-TRIMETHYL-2,6,10-DODECATRIENE]-L-CYSTEI
ARTHRICHITIN
15G256-GAMMA
Pentanamide, 2-(dimethylamino)-4-methyl-N-[2-methyl-1-[[3,3a,11,12,13,14,15,15a-octahydro-12,15-dioxo-13-(phenylmethyl)-5,8-ethenopyrrolo[3,2-b][1,5,8]oxadiazacyclotetradecin-1(2H)-yl]carbonyl]butyl]-
VERRUCAMIDE_C
| Title | Journal or Book | Year |
|---|---|---|
| Cyclothialidine Analogs, Novel DNA Gyrase Inhibitors. | The Journal of Antibiotics | 1997 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.